Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

First- and Second-Generation Antipsychotics for Children and Young Adults

Slide: 24 of 43

Summary of Results: Efficacy of Antipsychotics in Placebo Comparisons (1 of 2)

In the clinical literature about pediatric use of antipsychotics, the review found that second-generation antipsychotics (SGAs) result in greater improvement of disorder-specific symptoms when compared with placebo.

SGAs improve both clinical global impressions (CGIs) and positive and negative symptoms of schizophrenia, an approved indication for their use. The strength of evidence for this conclusion is moderate.

SGAs also improve CGIs and manic but not depressive symptoms of bipolar disorder. The strength of evidence for this conclusion is moderate for CGIs and low for manic and depressive symptoms.